← Back to patent-cliff list
CAS 1610595-16-8
N-(5-(benzyloxy)-2,4-di-tert-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
Codes：IVAC-032
Application context (from source-drug indications)
囊性纤维化艾伐卡托慢性支气管炎艾伐卡托慢性阻塞性肺疾病艾伐卡托鼻窦炎艾伐卡托
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 艾伐卡托Ivacaftor | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate→2,4-di-tert-butylphenol→2,4-di-tert-butyl-5-nitrophenol→1-(benzyloxy)-2,4-di-tert-butyl-5-nitrobenzene→5-(benzyloxy)-2,4-di-tert-butylaniline→N-(5-(benzyloxy)-2,4-di-tert-butylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.